Managing Chronic Migraine Through Treatment and Lifestyle Decisions: Dolores Santamaria, MD
The director of the Headache Center at Allegheny Health Network provided perspective on whether focusing in on medications or lifestyle choices has better impacts on improving chronic migraine. [WATCH TIME: 4 minutes]
WATCH TIME: 4 minutes
"It’s really important to understand the multidisciplinary approach. It’s not just one shot, come take a pill and go. You have to assess the patient and the different directions. That’s why I always work with a lot of holistic approaches, using a lot of vitamins, etc."
Chronic migraine is defined as having at least 15 headache days a month, with at least 8 days of having headaches with migraine features, for more than 3 months. This type of migraine begins with less frequent headache episodes that gradually change into a more frequent pattern over time. Approximately 3% to 5% of people in the US have chronic migraine, and approximately 3% of those with episodic migraine transform to chronic migraine each year.
Aside from the number of episodic headaches, there can be several factors that cause chronic migraine, including overusing medications designed to treat episodic migraines, obesity, snoring, mood disorders, ongoing disrupted sleep pattern, excessive caffeine intake, and history of emotional or physical trauma. There are several preventive treatments aimed at reducing the number of headaches, including beta blockers, angiotensin blockers, tricyclic antidepressants, anticonvulsants, onabotulinumtoxinA (Botox), and calcitonin gene-related peptides (CGRPs). In addition to medications, a lot of treating chronic migraine is focused on managing lifestyle choices and headache triggers.
Dolores Santamaria, MD, director of the Headache Center at
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Current Challenges and New Opportunities Ahead for Women in Neurology
September 15th 2025
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025